The MarketWatch News Department was not involved in the creation of this content. ATR-01, which uses a filaggrin-secreting strain of S. epidermidis, is in preclinical development for ichthyosis ...
When Christina Fleagle’s son Peyton was 18 months old, she noticed red scales on his skin. Soon after, he was diagnosed with ichthyosis, a rare condition that causes red or pink dry, rough scales on ...
Dosed first patient in Phase 1/2 trial for ATR-04 program targeting oncology patients with EGFRi-associated rash in August 2025 Presented positive preclinical data at BIO-Europe® for ATR-01 program, ...
Congenital ichthyosis disorders constitute a complex, genetically heterogeneous group of hereditary skin conditions marked by aberrant epidermal differentiation and impaired barrier function. These ...
BRANFORD, Conn., Oct. 20, 2025 /PRNewswire/ -- Azitra, Inc. (AZTR), a clinical stage biopharmaceutical company focused on developing innovative therapies for precision dermatology, today announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results